(2R)-N-[5-(5-methyl-1,1-dioxo-1,2,5-thiadiazolidin-2-yl)-2-pyridinyl]-2-[[(2S)-2-(4-methylphenyl)propyl]amino]-2-phenylacetamide;(2S)-N-[5-(5-methyl-1,1-dioxo-1,2,5-thiadiazolidin-2-yl)-2-pyridinyl]-2-[2-(4-methylphenyl)propylamino]-2-phenylacetamide;(2R)-N-[5-(5-methyl-1,2,4-oxadiazol-3-yl)-2-pyridinyl]-2-[[(2S)-2-(4-methylphenyl)propyl]amino]-2-phenylacetamide;(2S)-N-[5-(5-methyl-1,2,4-oxadiazol-3-yl)-2-pyridinyl]-2-[2-(4-methylphenyl)propylamino]-2-phenylacetamide;(2S)-N-[5-(1-methyl-5-oxopyrrolidin-3-yl)-2-pyridinyl]-2-[[(2S)-2-(4-methylphenyl)propyl]amino]-2-phenylacetamide;(2R)-N-[5-(1-methyl-5-oxopyrrolidin-3-yl)-2-pyridinyl]-2-[[(2S)-2-(4-methylphenyl)propyl]amino]-2-phenylacetamide;(2R)-N-[5-(1-methyl-5-oxopyrrolidin-3-yl)-2-pyridinyl]-2-[2-(4-methylphenyl)propylamino]-2-phenylacetamide

C188H212N32O16S2 — CID 167586473

About (2R)-N-[5-(5-methyl-1,1-dioxo-1,2,5-thiadiazolidin-2-yl)-2-pyridinyl]-2-[[(2S)-2-(4-methylphenyl)propyl]amino]-2-phenylacetamide;(2S)-N-[5-(5-methyl-1,1-dioxo-1,2,5-thiadiazolidin-2-yl)-2-pyridinyl]-2-[2-(4-methylphenyl)propylamino]-2-phenylacetamide;(2R)-N-[5-(5-methyl-1,2,4-oxadiazol-3-yl)-2-pyridinyl]-2-[[(2S)-2-(4-methylphenyl)propyl]amino]-2-phenylacetamide;(2S)-N-[5-(5-methyl-1,2,4-oxadiazol-3-yl)-2-pyridinyl]-2-[2-(4-methylphenyl)propylamino]-2-phenylacetamide;(2S)-N-[5-(1-methyl-5-oxopyrrolidin-3-yl)-2-pyridinyl]-2-[[(2S)-2-(4-methylphenyl)propyl]amino]-2-phenylacetamide;(2R)-N-[5-(1-methyl-5-oxopyrrolidin-3-yl)-2-pyridinyl]-2-[[(2S)-2-(4-methylphenyl)propyl]amino]-2-phenylacetamide;(2R)-N-[5-(1-methyl-5-oxopyrrolidin-3-yl)-2-pyridinyl]-2-[2-(4-methylphenyl)propylamino]-2-phenylacetamide

(2R)-N-[5-(5-methyl-1,1-dioxo-1,2,5-thiadiazolidin-2-yl)-2-pyridinyl]-2-[[(2S)-2-(4-methylphenyl)propyl]amino]-2-phenylacetamide;(2S)-N-[5-(5-methyl-1,1-dioxo-1,2,5-thiadiazolidin-2-yl)-2-pyridinyl]-2-[2-(4-methylphenyl)propylamino]-2-phenylacetamide;(2R)-N-[5-(5-methyl-1,2,4-oxadiazol-3-yl)-2-pyridinyl]-2-[[(2S)-2-(4-methylphenyl)propyl]amino]-2-phenylacetamide;(2S)-N-[5-(5-methyl-1,2,4-oxadiazol-3-yl)-2-pyridinyl]-2-[2-(4-methylphenyl)propylamino]-2-phenylacetamide;(2S)-N-[5-(1-methyl-5-oxopyrrolidin-3-yl)-2-pyridinyl]-2-[[(2S)-2-(4-methylphenyl)propyl]amino]-2-phenylacetamide;(2R)-N-[5-(1-methyl-5-oxopyrrolidin-3-yl)-2-pyridinyl]-2-[[(2S)-2-(4-methylphenyl)propyl]amino]-2-phenylacetamide;(2R)-N-[5-(1-methyl-5-oxopyrrolidin-3-yl)-2-pyridinyl]-2-[2-(4-methylphenyl)propylamino]-2-phenylacetamide (PubChem CID 167586473) has the molecular formula C188H212N32O16S2 and a molecular weight of 3240.11 g/mol. Its IUPAC name is (2R)-N-[5-(5-methyl-1,1-dioxo-1,2,5-thiadiazolidin-2-yl)-2-pyridinyl]-2-[[(2S)-2-(4-methylphenyl)propyl]amino]-2-phenylacetamide;(2S)-N-[5-(5-methyl-1,1-dioxo-1,2,5-thiadiazolidin-2-yl)-2-pyridinyl]-2-[2-(4-methylphenyl)propylamino]-2-phenylacetamide;(2R)-N-[5-(5-methyl-1,2,4-oxadiazol-3-yl)-2-pyridinyl]-2-[[(2S)-2-(4-methylphenyl)propyl]amino]-2-phenylacetamide;(2S)-N-[5-(5-methyl-1,2,4-oxadiazol-3-yl)-2-pyridinyl]-2-[2-(4-methylphenyl)propylamino]-2-phenylacetamide;(2S)-N-[5-(1-methyl-5-oxopyrrolidin-3-yl)-2-pyridinyl]-2-[[(2S)-2-(4-methylphenyl)propyl]amino]-2-phenylacetamide;(2R)-N-[5-(1-methyl-5-oxopyrrolidin-3-yl)-2-pyridinyl]-2-[[(2S)-2-(4-methylphenyl)propyl]amino]-2-phenylacetamide;(2R)-N-[5-(1-methyl-5-oxopyrrolidin-3-yl)-2-pyridinyl]-2-[2-(4-methylphenyl)propylamino]-2-phenylacetamide.

Molecular Properties

• Compound Name: (2R)-N-[5-(5-methyl-1,1-dioxo-1,2,5-thiadiazolidin-2-yl)-2-pyridinyl]-2-[[(2S)-2-(4-methylphenyl)propyl]amino]-2-phenylacetamide;(2S)-N-[5-(5-methyl-1,1-dioxo-1,2,5-thiadiazolidin-2-yl)-2-pyridinyl]-2-[2-(4-methylphenyl)propylamino]-2-phenylacetamide;(2R)-N-[5-(5-methyl-1,2,4-oxadiazol-3-yl)-2-pyridinyl]-2-[[(2S)-2-(4-methylphenyl)propyl]amino]-2-phenylacetamide;(2S)-N-[5-(5-methyl-1,2,4-oxadiazol-3-yl)-2-pyridinyl]-2-[2-(4-methylphenyl)propylamino]-2-phenylacetamide;(2S)-N-[5-(1-methyl-5-oxopyrrolidin-3-yl)-2-pyridinyl]-2-[[(2S)-2-(4-methylphenyl)propyl]amino]-2-phenylacetamide;(2R)-N-[5-(1-methyl-5-oxopyrrolidin-3-yl)-2-pyridinyl]-2-[[(2S)-2-(4-methylphenyl)propyl]amino]-2-phenylacetamide;(2R)-N-[5-(1-methyl-5-oxopyrrolidin-3-yl)-2-pyridinyl]-2-[2-(4-methylphenyl)propylamino]-2-phenylacetamide
• PubChem CID: 167586473
• Molecular Formula: C188H212N32O16S2
• Molecular Weight: 3240.11 g/mol
• Exact Mass: 3237.62
• IUPAC Name: (2R)-N-[5-(5-methyl-1,1-dioxo-1,2,5-thiadiazolidin-2-yl)-2-pyridinyl]-2-[[(2S)-2-(4-methylphenyl)propyl]amino]-2-phenylacetamide;(2S)-N-[5-(5-methyl-1,1-dioxo-1,2,5-thiadiazolidin-2-yl)-2-pyridinyl]-2-[2-(4-methylphenyl)propylamino]-2-phenylacetamide;(2R)-N-[5-(5-methyl-1,2,4-oxadiazol-3-yl)-2-pyridinyl]-2-[[(2S)-2-(4-methylphenyl)propyl]amino]-2-phenylacetamide;(2S)-N-[5-(5-methyl-1,2,4-oxadiazol-3-yl)-2-pyridinyl]-2-[2-(4-methylphenyl)propylamino]-2-phenylacetamide;(2S)-N-[5-(1-methyl-5-oxopyrrolidin-3-yl)-2-pyridinyl]-2-[[(2S)-2-(4-methylphenyl)propyl]amino]-2-phenylacetamide;(2R)-N-[5-(1-methyl-5-oxopyrrolidin-3-yl)-2-pyridinyl]-2-[[(2S)-2-(4-methylphenyl)propyl]amino]-2-phenylacetamide;(2R)-N-[5-(1-methyl-5-oxopyrrolidin-3-yl)-2-pyridinyl]-2-[2-(4-methylphenyl)propylamino]-2-phenylacetamide
• SMILES: Cc1ccc(C(C)CN[C@@H](C(=O)Nc2ccc(C3CC(=O)N(C)C3)cn2)c2ccccc2)cc1.Cc1ccc(C(C)CN[C@H](C(=O)Nc2ccc(-c3noc(C)n3)cn2)c2ccccc2)cc1.Cc1ccc(C(C)CN[C@H](C(=O)Nc2ccc(N3CCN(C)S3(=O)=O)cn2)c2ccccc2)cc1.Cc1ccc([C@H](C)CN[C@@H](C(=O)Nc2ccc(-c3noc(C)n3)cn2)c2ccccc2)cc1.Cc1ccc([C@H](C)CN[C@@H](C(=O)Nc2ccc(C3CC(=O)N(C)C3)cn2)c2ccccc2)cc1.Cc1ccc([C@H](C)CN[C@@H](C(=O)Nc2ccc(N3CCN(C)S3(=O)=O)cn2)c2ccccc2)cc1.Cc1ccc([C@H](C)CN[C@H](C(=O)Nc2ccc(C3CC(=O)N(C)C3)cn2)c2ccccc2)cc1
• InChI: InChI=1S/3C28H32N4O2.2C26H31N5O3S.2C26H27N5O2/c3*1-19-9-11-21(12-10-19)20(2)16-30-27(22-7-5-4-6-8-22)28(34)31-25-14-13-23(17-29-25)24-15-26(33)32(3)18-24;2*1-19-9-11-21(12-10-19)20(2)17-28-25(22-7-5-4-6-8-22)26(32)29-24-14-13-23(18-27-24)31-16-15-30(3)35(31,33)34;2*1-17-9-11-20(12-10-17)18(2)15-28-24(21-7-5-4-6-8-21)26(32)30-23-14-13-22(16-27-23)25-29-19(3)33-31-25/h3*4-14,17,20,24,27,30H,15-16,18H2,1-3H3,(H,29,31,34);2*4-14,18,20,25,28H,15-17H2,1-3H3,(H,27,29,32);2*4-14,16,18,24,28H,15H2,1-3H3,(H,27,30,32)/t20?,24?,27-;20-,24?,27+;20-,24?,27-;20?,25-;20-,25-;18?,24-;18-,24-/m1110101/s1
• InChIKey: HWFNLMKJKNFRLA-MJAFMQRCSA-N
• XLogP: 29.79
• TPSA: 598.15 Ų
• H-Bond Donors: 14
• H-Bond Acceptors: 34
• Rotatable Bonds: 56
• Heavy Atoms: 238
• Complexity: —

Lipinski Rule of Five

4 violations

Rule	Value
MW ≤ 500	3240.11
LogP ≤ 5	29.79
H-Bond Donors ≤ 5	14
H-Bond Acceptors ≤ 10	34

Frequently Asked Questions

What is the IUPAC name of (2R)-N-[5-(5-methyl-1,1-dioxo-1,2,5-thiadiazolidin-2-yl)-2-pyridinyl]-2-[[(2S)-2-(4-methylphenyl)propyl]amino]-2-phenylacetamide;(2S)-N-[5-(5-methyl-1,1-dioxo-1,2,5-thiadiazolidin-2-yl)-2-pyridinyl]-2-[2-(4-methylphenyl)propylamino]-2-phenylacetamide;(2R)-N-[5-(5-methyl-1,2,4-oxadiazol-3-yl)-2-pyridinyl]-2-[[(2S)-2-(4-methylphenyl)propyl]amino]-2-phenylacetamide;(2S)-N-[5-(5-methyl-1,2,4-oxadiazol-3-yl)-2-pyridinyl]-2-[2-(4-methylphenyl)propylamino]-2-phenylacetamide;(2S)-N-[5-(1-methyl-5-oxopyrrolidin-3-yl)-2-pyridinyl]-2-[[(2S)-2-(4-methylphenyl)propyl]amino]-2-phenylacetamide;(2R)-N-[5-(1-methyl-5-oxopyrrolidin-3-yl)-2-pyridinyl]-2-[[(2S)-2-(4-methylphenyl)propyl]amino]-2-phenylacetamide;(2R)-N-[5-(1-methyl-5-oxopyrrolidin-3-yl)-2-pyridinyl]-2-[2-(4-methylphenyl)propylamino]-2-phenylacetamide?

The IUPAC name of (2R)-N-[5-(5-methyl-1,1-dioxo-1,2,5-thiadiazolidin-2-yl)-2-pyridinyl]-2-[[(2S)-2-(4-methylphenyl)propyl]amino]-2-phenylacetamide;(2S)-N-[5-(5-methyl-1,1-dioxo-1,2,5-thiadiazolidin-2-yl)-2-pyridinyl]-2-[2-(4-methylphenyl)propylamino]-2-phenylacetamide;(2R)-N-[5-(5-methyl-1,2,4-oxadiazol-3-yl)-2-pyridinyl]-2-[[(2S)-2-(4-methylphenyl)propyl]amino]-2-phenylacetamide;(2S)-N-[5-(5-methyl-1,2,4-oxadiazol-3-yl)-2-pyridinyl]-2-[2-(4-methylphenyl)propylamino]-2-phenylacetamide;(2S)-N-[5-(1-methyl-5-oxopyrrolidin-3-yl)-2-pyridinyl]-2-[[(2S)-2-(4-methylphenyl)propyl]amino]-2-phenylacetamide;(2R)-N-[5-(1-methyl-5-oxopyrrolidin-3-yl)-2-pyridinyl]-2-[[(2S)-2-(4-methylphenyl)propyl]amino]-2-phenylacetamide;(2R)-N-[5-(1-methyl-5-oxopyrrolidin-3-yl)-2-pyridinyl]-2-[2-(4-methylphenyl)propylamino]-2-phenylacetamide (CID 167586473) is (2R)-N-[5-(5-methyl-1,1-dioxo-1,2,5-thiadiazolidin-2-yl)-2-pyridinyl]-2-[[(2S)-2-(4-methylphenyl)propyl]amino]-2-phenylacetamide;(2S)-N-[5-(5-methyl-1,1-dioxo-1,2,5-thiadiazolidin-2-yl)-2-pyridinyl]-2-[2-(4-methylphenyl)propylamino]-2-phenylacetamide;(2R)-N-[5-(5-methyl-1,2,4-oxadiazol-3-yl)-2-pyridinyl]-2-[[(2S)-2-(4-methylphenyl)propyl]amino]-2-phenylacetamide;(2S)-N-[5-(5-methyl-1,2,4-oxadiazol-3-yl)-2-pyridinyl]-2-[2-(4-methylphenyl)propylamino]-2-phenylacetamide;(2S)-N-[5-(1-methyl-5-oxopyrrolidin-3-yl)-2-pyridinyl]-2-[[(2S)-2-(4-methylphenyl)propyl]amino]-2-phenylacetamide;(2R)-N-[5-(1-methyl-5-oxopyrrolidin-3-yl)-2-pyridinyl]-2-[[(2S)-2-(4-methylphenyl)propyl]amino]-2-phenylacetamide;(2R)-N-[5-(1-methyl-5-oxopyrrolidin-3-yl)-2-pyridinyl]-2-[2-(4-methylphenyl)propylamino]-2-phenylacetamide.

What is the SMILES notation for (2R)-N-[5-(5-methyl-1,1-dioxo-1,2,5-thiadiazolidin-2-yl)-2-pyridinyl]-2-[[(2S)-2-(4-methylphenyl)propyl]amino]-2-phenylacetamide;(2S)-N-[5-(5-methyl-1,1-dioxo-1,2,5-thiadiazolidin-2-yl)-2-pyridinyl]-2-[2-(4-methylphenyl)propylamino]-2-phenylacetamide;(2R)-N-[5-(5-methyl-1,2,4-oxadiazol-3-yl)-2-pyridinyl]-2-[[(2S)-2-(4-methylphenyl)propyl]amino]-2-phenylacetamide;(2S)-N-[5-(5-methyl-1,2,4-oxadiazol-3-yl)-2-pyridinyl]-2-[2-(4-methylphenyl)propylamino]-2-phenylacetamide;(2S)-N-[5-(1-methyl-5-oxopyrrolidin-3-yl)-2-pyridinyl]-2-[[(2S)-2-(4-methylphenyl)propyl]amino]-2-phenylacetamide;(2R)-N-[5-(1-methyl-5-oxopyrrolidin-3-yl)-2-pyridinyl]-2-[[(2S)-2-(4-methylphenyl)propyl]amino]-2-phenylacetamide;(2R)-N-[5-(1-methyl-5-oxopyrrolidin-3-yl)-2-pyridinyl]-2-[2-(4-methylphenyl)propylamino]-2-phenylacetamide?

The canonical SMILES for (2R)-N-[5-(5-methyl-1,1-dioxo-1,2,5-thiadiazolidin-2-yl)-2-pyridinyl]-2-[[(2S)-2-(4-methylphenyl)propyl]amino]-2-phenylacetamide;(2S)-N-[5-(5-methyl-1,1-dioxo-1,2,5-thiadiazolidin-2-yl)-2-pyridinyl]-2-[2-(4-methylphenyl)propylamino]-2-phenylacetamide;(2R)-N-[5-(5-methyl-1,2,4-oxadiazol-3-yl)-2-pyridinyl]-2-[[(2S)-2-(4-methylphenyl)propyl]amino]-2-phenylacetamide;(2S)-N-[5-(5-methyl-1,2,4-oxadiazol-3-yl)-2-pyridinyl]-2-[2-(4-methylphenyl)propylamino]-2-phenylacetamide;(2S)-N-[5-(1-methyl-5-oxopyrrolidin-3-yl)-2-pyridinyl]-2-[[(2S)-2-(4-methylphenyl)propyl]amino]-2-phenylacetamide;(2R)-N-[5-(1-methyl-5-oxopyrrolidin-3-yl)-2-pyridinyl]-2-[[(2S)-2-(4-methylphenyl)propyl]amino]-2-phenylacetamide;(2R)-N-[5-(1-methyl-5-oxopyrrolidin-3-yl)-2-pyridinyl]-2-[2-(4-methylphenyl)propylamino]-2-phenylacetamide is Cc1ccc(C(C)CN[C@@H](C(=O)Nc2ccc(C3CC(=O)N(C)C3)cn2)c2ccccc2)cc1.Cc1ccc(C(C)CN[C@H](C(=O)Nc2ccc(-c3noc(C)n3)cn2)c2ccccc2)cc1.Cc1ccc(C(C)CN[C@H](C(=O)Nc2ccc(N3CCN(C)S3(=O)=O)cn2)c2ccccc2)cc1.Cc1ccc([C@H](C)CN[C@@H](C(=O)Nc2ccc(-c3noc(C)n3)cn2)c2ccccc2)cc1.Cc1ccc([C@H](C)CN[C@@H](C(=O)Nc2ccc(C3CC(=O)N(C)C3)cn2)c2ccccc2)cc1.Cc1ccc([C@H](C)CN[C@@H](C(=O)Nc2ccc(N3CCN(C)S3(=O)=O)cn2)c2ccccc2)cc1.Cc1ccc([C@H](C)CN[C@H](C(=O)Nc2ccc(C3CC(=O)N(C)C3)cn2)c2ccccc2)cc1.

What is the InChIKey of (2R)-N-[5-(5-methyl-1,1-dioxo-1,2,5-thiadiazolidin-2-yl)-2-pyridinyl]-2-[[(2S)-2-(4-methylphenyl)propyl]amino]-2-phenylacetamide;(2S)-N-[5-(5-methyl-1,1-dioxo-1,2,5-thiadiazolidin-2-yl)-2-pyridinyl]-2-[2-(4-methylphenyl)propylamino]-2-phenylacetamide;(2R)-N-[5-(5-methyl-1,2,4-oxadiazol-3-yl)-2-pyridinyl]-2-[[(2S)-2-(4-methylphenyl)propyl]amino]-2-phenylacetamide;(2S)-N-[5-(5-methyl-1,2,4-oxadiazol-3-yl)-2-pyridinyl]-2-[2-(4-methylphenyl)propylamino]-2-phenylacetamide;(2S)-N-[5-(1-methyl-5-oxopyrrolidin-3-yl)-2-pyridinyl]-2-[[(2S)-2-(4-methylphenyl)propyl]amino]-2-phenylacetamide;(2R)-N-[5-(1-methyl-5-oxopyrrolidin-3-yl)-2-pyridinyl]-2-[[(2S)-2-(4-methylphenyl)propyl]amino]-2-phenylacetamide;(2R)-N-[5-(1-methyl-5-oxopyrrolidin-3-yl)-2-pyridinyl]-2-[2-(4-methylphenyl)propylamino]-2-phenylacetamide?

The InChIKey is HWFNLMKJKNFRLA-MJAFMQRCSA-N. The full InChI is InChI=1S/3C28H32N4O2.2C26H31N5O3S.2C26H27N5O2/c3*1-19-9-11-21(12-10-19)20(2)16-30-27(22-7-5-4-6-8-22)28(34)31-25-14-13-23(17-29-25)24-15-26(33)32(3)18-24;2*1-19-9-11-21(12-10-19)20(2)17-28-25(22-7-5-4-6-8-22)26(32)29-24-14-13-23(18-27-24)31-16-15-30(3)35(31,33)34;2*1-17-9-11-20(12-10-17)18(2)15-28-24(21-7-5-4-6-8-21)26(32)30-23-14-13-22(16-27-23)25-29-19(3)33-31-25/h3*4-14,17,20,24,27,30H,15-16,18H2,1-3H3,(H,29,31,34);2*4-14,18,20,25,28H,15-17H2,1-3H3,(H,27,29,32);2*4-14,16,18,24,28H,15H2,1-3H3,(H,27,30,32)/t20?,24?,27-;20-,24?,27+;20-,24?,27-;20?,25-;20-,25-;18?,24-;18-,24-/m1110101/s1.

What are the key properties of (2R)-N-[5-(5-methyl-1,1-dioxo-1,2,5-thiadiazolidin-2-yl)-2-pyridinyl]-2-[[(2S)-2-(4-methylphenyl)propyl]amino]-2-phenylacetamide;(2S)-N-[5-(5-methyl-1,1-dioxo-1,2,5-thiadiazolidin-2-yl)-2-pyridinyl]-2-[2-(4-methylphenyl)propylamino]-2-phenylacetamide;(2R)-N-[5-(5-methyl-1,2,4-oxadiazol-3-yl)-2-pyridinyl]-2-[[(2S)-2-(4-methylphenyl)propyl]amino]-2-phenylacetamide;(2S)-N-[5-(5-methyl-1,2,4-oxadiazol-3-yl)-2-pyridinyl]-2-[2-(4-methylphenyl)propylamino]-2-phenylacetamide;(2S)-N-[5-(1-methyl-5-oxopyrrolidin-3-yl)-2-pyridinyl]-2-[[(2S)-2-(4-methylphenyl)propyl]amino]-2-phenylacetamide;(2R)-N-[5-(1-methyl-5-oxopyrrolidin-3-yl)-2-pyridinyl]-2-[[(2S)-2-(4-methylphenyl)propyl]amino]-2-phenylacetamide;(2R)-N-[5-(1-methyl-5-oxopyrrolidin-3-yl)-2-pyridinyl]-2-[2-(4-methylphenyl)propylamino]-2-phenylacetamide?

(2R)-N-[5-(5-methyl-1,1-dioxo-1,2,5-thiadiazolidin-2-yl)-2-pyridinyl]-2-[[(2S)-2-(4-methylphenyl)propyl]amino]-2-phenylacetamide;(2S)-N-[5-(5-methyl-1,1-dioxo-1,2,5-thiadiazolidin-2-yl)-2-pyridinyl]-2-[2-(4-methylphenyl)propylamino]-2-phenylacetamide;(2R)-N-[5-(5-methyl-1,2,4-oxadiazol-3-yl)-2-pyridinyl]-2-[[(2S)-2-(4-methylphenyl)propyl]amino]-2-phenylacetamide;(2S)-N-[5-(5-methyl-1,2,4-oxadiazol-3-yl)-2-pyridinyl]-2-[2-(4-methylphenyl)propylamino]-2-phenylacetamide;(2S)-N-[5-(1-methyl-5-oxopyrrolidin-3-yl)-2-pyridinyl]-2-[[(2S)-2-(4-methylphenyl)propyl]amino]-2-phenylacetamide;(2R)-N-[5-(1-methyl-5-oxopyrrolidin-3-yl)-2-pyridinyl]-2-[[(2S)-2-(4-methylphenyl)propyl]amino]-2-phenylacetamide;(2R)-N-[5-(1-methyl-5-oxopyrrolidin-3-yl)-2-pyridinyl]-2-[2-(4-methylphenyl)propylamino]-2-phenylacetamide has a molecular weight of 3240.11 g/mol, XLogP of 29.79, 56 rotatable bonds, 14 hydrogen bond donors, and 34 hydrogen bond acceptors.

Where does this data come from?

All data for (2R)-N-[5-(5-methyl-1,1-dioxo-1,2,5-thiadiazolidin-2-yl)-2-pyridinyl]-2-[[(2S)-2-(4-methylphenyl)propyl]amino]-2-phenylacetamide;(2S)-N-[5-(5-methyl-1,1-dioxo-1,2,5-thiadiazolidin-2-yl)-2-pyridinyl]-2-[2-(4-methylphenyl)propylamino]-2-phenylacetamide;(2R)-N-[5-(5-methyl-1,2,4-oxadiazol-3-yl)-2-pyridinyl]-2-[[(2S)-2-(4-methylphenyl)propyl]amino]-2-phenylacetamide;(2S)-N-[5-(5-methyl-1,2,4-oxadiazol-3-yl)-2-pyridinyl]-2-[2-(4-methylphenyl)propylamino]-2-phenylacetamide;(2S)-N-[5-(1-methyl-5-oxopyrrolidin-3-yl)-2-pyridinyl]-2-[[(2S)-2-(4-methylphenyl)propyl]amino]-2-phenylacetamide;(2R)-N-[5-(1-methyl-5-oxopyrrolidin-3-yl)-2-pyridinyl]-2-[[(2S)-2-(4-methylphenyl)propyl]amino]-2-phenylacetamide;(2R)-N-[5-(1-methyl-5-oxopyrrolidin-3-yl)-2-pyridinyl]-2-[2-(4-methylphenyl)propylamino]-2-phenylacetamide is sourced from PubChem (CID 167586473), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).